PolarCool AB (publ.), the Swedish med-tech company behind the concussion treatment product PolarCap®, has renewed its agreement with English Premiership Rugby team Bristol Bears. The extension, which runs for another two years, reinforces PolarCool’s growing footprint in professional rugby.

PolarCool develops and markets the product PolarCap®, which alleviates the effects of concussion. The UK and European rugby markets remain a central focus for PolarCool’s expansion strategy. The extended partnership with Bristol Bears—a premier club competing in England’s top-tier Gallagher Premiership - marks a significant step in the company’s growth. As one of the leading rugby organizations in the UK, Bristol Bears plays a key role in strengthening PolarCool’s presence in elite-level sport across the region.

PolarCool CEO Erik Andersson comments

-Bristol Bears have built a reputation for high performance standards and strong player care. The fact that the club continues to use PolarCap® is, in my view, a testament to their appreciation of the product’s value as an acute treatment for sports-related concussions and their commitment to player wellbeing.

The United Kingdom remains a key market for PolarCool, with a numerous professional teams in both professional rugby and football. Following the recent signing of Southampton FC, a leading English football club, alongside the renewed agreement with Bristol Bears, PolarCool continues to expand its footprint across both sports.

PolarCool’s goal is to continue to strengthen its presence in international rugby and the agreement therefore brings strategic value.

For more information

Erik Andersson –  CEO PolarCool AB (publ.)               
+46 - 738 60 57 00                                         
E-mail: erik.andersson@polarcool.se